Ian Edvalson is a technology transactions partner in Wilson Sonsini Goodrich & Rosati’s Palo Alto office and a former member of the firm’s board of directors. Ian advises numerous domestic and international public and private biopharmaceutical, medtech, and life sciences companies with all of the transactions related to the discovery, development, supply, and commercialization of their products, technologies, and services. He counsels clients with respect to the structuring and negotiating of a wide range of arrangements designed to maximize the value of their businesses. Ian specializes in working with his clients on the most complex strategic alliances and joint ventures for the development and marketing of all stages of pharmaceutical and other products. In addition, he helps companies with a broad range of other transactions, including technology and asset acquisition, license, discovery, research, development (including clinical development), manufacture and supply, promotion, marketing, distribution, and services agreements.I an draws on his almost 30 years of business and legal experience (including his time leading the corporate and business development functions at Third Wave Technologies, a public genomics company) to address the full range of issues and transactions facing biopharmaceutical, medtech, and life sciences companies. He works closely with his clients in setting strategic direction and structuring and negotiating mission-critical business arrangements.